Amgen (AMGN) Income from Continuing Operations (2009 - 2026)

Amgen (AMGN) has reported Income from Continuing Operations for 18 consecutive years, with 1819000000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Income from Continuing Operations rose 5.14% year-over-year to 1819000000.0; the TTM figure through Mar 2026 stood at 7800000000.0 (up 31.47% YoY), while the FY2025 annual figure was 7711000000.0, up 88.53% from the prior year.
• Income from Continuing Operations came in at 1819000000.0 for Q1 2026 at Amgen, up from 1333000000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 3216000000.0 in Q3 2025, with the low at 113000000.0 in Q1 2024.
• Average Income from Continuing Operations over 5 years is 1581705882.35, with a median of 1476000000.0 recorded in 2022.
• Across the five-year window, Income from Continuing Operations sank 103.98% in 2024 and surged 1630.97% in 2025, its largest moves.
• Year by year, Income from Continuing Operations stood at 1616000000.0 in 2022, then tumbled by 52.54% to 767000000.0 in 2023, then dropped by 18.25% to 627000000.0 in 2024, then soared by 112.6% to 1333000000.0 in 2025, then surged by 36.46% to 1819000000.0 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 1819000000.0, 1333000000.0, and 3216000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.